Man Group’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.9M Buy
461,898
+155,155
+51% +$5.09M 0.02% 698
2025
Q4
$11.5M Buy
306,743
+29,681
+11% +$976K 0.02% 732
2025
Q3
$7.64M Buy
277,062
+24,443
+10% +$842K 0.01% 908
2025
Q2
$7.98M Buy
252,619
+65,252
+35% +$2.1M 0.02% 865
2025
Q1
$6.22M Sell
187,367
-26,746
-12% -$959K 0.02% 926
2024
Q4
$7.37M Buy
214,113
+58,642
+38% +$2.01M 0.02% 851
2024
Q3
$6.22M Sell
155,471
-2,127
-1% -$74.7K 0.02% 946
2024
Q2
$4.75M Buy
157,598
+13,039
+9% +$392K 0.01% 1026
2024
Q1
$4.85M Buy
144,559
+5,215
+4% +$167K 0.01% 1006
2023
Q4
$4.5M Buy
+139,344
New +$3.89M 0.01% 985
2023
Q3
Sell
-318,899
Closed -$11.1M 1028
2023
Q2
$11.2M Buy
+318,899
New +$11M 0.03% 585
2023
Q1
Sell
-237,002
Closed -$10.8M 806
2022
Q4
$13.1M Sell
237,002
-32,622
-12% -$1.79M 0.05% 467
2022
Q3
$11.9M Buy
+269,624
New +$13.2M 0.06% 420
2022
Q2
Sell
-117,970
Closed -$5.31M 477
2022
Q1
$5.74M Buy
117,970
+101,329
+609% +$4.13M 0.02% 834
2021
Q4
$710K Buy
16,641
+10,411
+167% +$415K ﹤0.01% 1427
2021
Q3
$239K Buy
+6,230
New +$201K ﹤0.01% 1710

Other funds holding HRMY